Article
Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patients
2022-11-13
Abstract excerpt
Understanding early innate immune responses to coronavirus disease 2019 (COVID–19) is crucial to developing targeted therapies to mitigate disease severity. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection elicits interferon expression leading to transcription of IFN-stimulated genes (ISGs) to control viral replication and spread. SARS-CoV-2 infection also elicits NF-κB signaling which regulate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cc946d69-23cb-5ccf-a71e-54a0a427ae32
- DOI
- 10.1101/2022.11.08.22281846
